The legislation gives companies more wiggle room, but most of them don't want it and are not going to use it. Patients are "no better off today with Right to Try than [they were] yesterday," says Arthur Caplan, head of medical ethics at NYU School of Medicine. In other pharma news: lawmakers want companies to develop new antibiotics but they're not offering any extra incentives for them to do so; Sen. Claire McCaskill (D-Mo.) wants to increase transparency over payments to patient advocacy groups; tips on getting around pharmacists' gag rule; and more.
from Kaiser Health News https://ift.tt/2Jp4N9Q
June 07, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Viewpoints: A Year After The Parkland Mass Shootings, Serious Gun Reforms Are Missing; What’s The Holdup In Getting Health Care For These Veterans?Opinion writers weigh in on these and other health topics. from Kaiser Health News http://bit.ly/2GpoikM … Read More
Perspectives: Bitterly Divided Government Hasn’t Prevented Lawmakers From Moving Forward On Drug PricesRead recent commentaries about drug-cost issues. from Kaiser Health News http://bit.ly/2GoHi2U … Read More
Can California Beat The Federal Government In Lowering Drug Prices?… Read More
Different Takes: Lessons On How To Wipe Out Fear Of Vaccines; Vitamin A Isn’t Going To Cut It When It Comes To Preventing MeaslesOpinion writers weigh in on the current measles epidemic. from Kaiser Health News http://bit.ly/2IapF8G … Read More
Pharmacy Benefit Managers Are Drawing Fire From All Directions In Debate Over Drug PricingNews outlets report on stories related to pharmaceutical pricing. from Kaiser Health News http://bit.ly/2Ib8wvy … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment